| MA-GS (n = 49) | MA-BS (n = 21) | Test value (t/χ2/Z) | p value |
---|---|---|---|---|
Demographic characteristics | ||||
Age (years) | 38.98 ± 9.65 | 39.95 ± 11.31 | -0.367 | 0.715†|
Gender (male) | 35 (71.43%) | 14 (66.67%) | 0.158 | 0.690# |
BMI (kg/m2) | 25.95 ± 3.43 | 25.79 ± 4.68 | 0.164 | 0.870†|
Smoking (Yes) | 49 (100%) | 20 (95.24%) | 0.915 | 0.339# |
Addiction characteristics | ||||
Initial age of methamphetamine use | 30.37 ± 8.57 | 30.05 ± 10.8 | 0.729 | 0.469†|
Duration of abstinence (months) | 2.00 (5.00) | 2.00 (6.00) | -0.026 | 0.979* |
Clinical characteristics | ||||
Pittsburgh Sleep Quality Index (PSQI) | 3.00 (4.00) | 12.00 (4.00) | -6.630 | < 0.001* |
Sleep quality | 0.00 (1.00) | 2.00 (2.00) | -6.137 | < 0.001* |
Sleep latency | 1.00 (1.00) | 2.00 (1.00) | -5.117 | < 0.001* |
Sleep duration | 1.00 (2.00) | 2.00 (2.00) | -3.802 | < 0.001* |
Habitual sleep efficiency | 0.00 (1.00) | 1.00 (3.00) | -2.914 | 0.004* |
Sleep disturbance | 0.00 (1.00) | 2.00 (1.00) | -6.178 | < 0.001* |
Use of sleeping medication | 0.00 (0.00) | 0.00 (2.00) | -4.171 | 0.003* |
Daytime dysfunction | 0.00 (0.00) | 2.00 (1.00) | -6.038 | < 0.001* |
Beck Depression Inventory (BDI) | 0.00 (7.00) | 4.00 (11.00) | -1.301 | 0.193* |
Beck Anxiety Inventory (BAI) | 0.00 (4.00) | 3.00 (9.00) | -1.599 | 0.110* |
Visual Analog Scale (VAS) | 0.00 (0.00) | 0.00 (0.00) | -0.192 | 0.848* |